Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

8.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.1K
Combinatorial Gene Control02:33

Combinatorial Gene Control

8.6K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computer-guided enzyme engineering of PET hydrolase mutants towards improved PET affinity.

BMC biotechnology·2026
Same author

External validation of a machine learning model for delivery mode prediction after induction.

NPJ digital medicine·2026
Same author

Endovascular treatment vs. best medical management for late window ischemic stroke patients with large vessel occlusion.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2025
Same author

Manometric and clinical characterization of non-obstructive esophageal dysphagia focusing on its impact on quality of life.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2025
Same author

A rare pancreatic retention cyst mimicking neoplastic lesions: A case report.

International journal of surgery case reports·2025
Same author

Not Quite Achalasia: Getting to the GIST of it.

Digestive diseases and sciences·2025

Related Experiment Video

Updated: Oct 15, 2025

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

3.9K

Generative Deep Learning for Targeted Compound Design.

Tiago Sousa1, João Correia1, Vítor Pereira1

  • 1Centre of Biological Engineering, Campus Gualtar, University of Minho, 4710-057 Braga, Portugal.

Journal of Chemical Information and Modeling
|October 26, 2021
PubMed
Summary
This summary is machine-generated.

Deep learning generative models create novel molecules for drug discovery and materials science. Optimization strategies guide this *de novo* molecular design for desired properties and activities.

Keywords:
ArchitecturesAutoencodersDe Novo Molecular DesignDeep LearningGenerative Adversarial NetworksGenerative ModelOptimizationRecurrent Neural Networks

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.8K

Related Experiment Videos

Last Updated: Oct 15, 2025

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

3.9K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
09:22

A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

Published on: June 22, 2015

14.8K

Area of Science:

  • Computational chemistry
  • Artificial intelligence in chemistry
  • Molecular modeling

Background:

  • *De novo* molecular design utilizes generative models from Deep Learning.
  • Applications span drug discovery, materials science, and biotechnology.
  • Deep generative models (e.g., RNNs, Autoencoders, GANs) learn from data to propose novel compounds.

Purpose of the Study:

  • To systematically review deep generative models for targeted compound design.
  • To critically analyze related optimization methods.
  • To discuss applications in various scientific fields.

Main Methods:

  • Review of deep generative model architectures (RNNs, Autoencoders, GANs).
  • Analysis of optimization strategies (transfer learning, Bayesian optimization, reinforcement learning, conditional generation).
  • Examination of model training on existing datasets and property distribution adherence.

Main Results:

  • Deep generative models can generate novel compounds with desired properties.
  • Optimization strategies effectively direct compound generation towards specific aims (biological activity, synthesis, chemical features).
  • These models offer a powerful approach to *de novo* molecular design.

Conclusions:

  • Deep generative models and optimization techniques are revolutionizing targeted compound design.
  • This review provides a critical overview of current methodologies and applications.
  • The field holds significant promise for accelerating scientific discovery.